Press Releases

Press Releases

Filters
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
Mylan Wins Dismissal of Kansas EpiPen® Direct Purchaser Case
Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021
Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action
Viatris Inc. to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
Viatris Inc. Releases Inaugural Sustainability Report, Reinforcing its Commitment to Better Health and Better Communities Worldwide
Viatris Inc. to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
Viatris Inc. to Participate in BofA Securities 2021 Health Care Conference
Viatris Inc. to Release First Quarter 2021 Financial Results on May 10, 2021
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
Displaying 1 - 10 of 21